Electromed (ELMD)
Prescription SmartVest airway-clearance systems with direct homecare reimbursement and support.
$28.33
At close+1.23 (+4.54%)
In millions of USD, except per-share figures
| In millions | Q1 FY24Sep 2023 | Q2 FY24Dec 2023 | Q3 FY24Mar 2024 | Q4 FY24Jun 2024 | Q1 FY25Sep 2024 | Q2 FY25Dec 2024 | Q3 FY25Mar 2025 | Q4 FY25Jun 2025 | Q1 FY26Sep 2025 | Q2 FY26Dec 2025 | Q3 FY26Mar 2026 | Q4 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 12 | 14 | 14 | 15 | 15 | 16 | 16 | 17 | 17 | 19 | 19 | 19 |
| Cost of revenue | 3 | 3 | 3 | 4 | 3 | 4 | 3 | 4 | 4 | 4 | 4 | 4 |
| Gross profit | 9 | 11 | 10 | 11 | 11 | 13 | 12 | 14 | 13 | 15 | 15 | 15 |
| 9 | 8 | 9 | 9 | 10 | 10 | 10 | 10 | 11 | 11 | 11 | 11 | |
| Research & development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 9 | 8 | 8 | 9 | 9 | 10 | 10 | 10 | 10 | 11 | 11 | 11 | |
| Selling & marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & administrative | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 0 | 0 |
| Operating income | 0 | 2 | 2 | 2 | 2 | 3 | 2 | 3 | 3 | 4 | 4 | 4 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income before tax | 0 | 2 | 2 | 2 | 2 | 3 | 2 | 3 | 3 | 4 | 4 | 4 |
| Income tax expense | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
| Net income from continuing operations | 0 | 2 | 1 | 2 | 1 | 2 | 2 | 2 | 2 | 3 | 3 | 3 |
| Net income | 0 | 2 | 1 | 2 | 1 | 2 | 2 | 2 | 2 | 3 | 3 | 3 |
| EPS, basic | $0.02 | $0.20 | $0.17 | $0.20 | $0.17 | $0.23 | $0.22 | $0.26 | $0.26 | $0.33 | $0.37 | $0.41 |
| EPS, diluted | $0.02 | $0.19 | $0.17 | $0.20 | $0.16 | $0.22 | $0.21 | $0.25 | $0.25 | $0.32 | $0.35 | $0.39 |
| Weighted average shares, basic | 9 | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 8 | 8 | 8 |
| Weighted average shares, diluted | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 |
| EBITDA | 0 | 3 | 2 | 3 | 2 | 3 | 3 | 4 | 3 | 4 | 4 | 4 |
| Depreciation & amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | 0 | 2 | 2 | 2 | 2 | 3 | 2 | 3 | 3 | 4 | 4 | 4 |